Masson Kristina 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 16, 2023
Insider Transaction Report
Form 4
Masson Kristina
DirectorEVP - Business Operations
Transactions
- Tax Payment
Common Stock
2023-11-14$5.08/sh−1,900$9,652→ 318,805 total
Holdings
- 2,658,673(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
- [F2]These securities are held by President and CEO, Peter Blume-Jensen, who is also Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.